Valuation: Guided Therapeutics, Inc.

Market Cap 28M 24.26M 22.71M 20.72M 39M 2.67B 39.65M 266M 104M 1.34B 105M 103M 4.46B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 30.87M 26.75M 25.05M 22.85M 43M 2.94B 43.73M 294M 115M 1.47B 116M 113M 4.92B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Current month-3.33%
1 month-3.33%
3 months+31.82%
6 months-6.45%
Current year-46.30%
1 month 0.24
Extreme 0.244
0.3
Current year 0.17
Extreme 0.17
0.54
1 year 0.15
Extreme 0.15
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 2023-03-05
Chief Tech/Sci/R&D Officer 70 2010-12-01
Director TitleAgeSince
Director/Board Member 70 2016-11-30
Director/Board Member 76 2006-04-09
Chairman 67 2013-09-30
Date Insider Type Main position Quantity % Market Cap.
2/25/26 Others

Director

260 25.3411%
2/25/26 Option

Chairman

600,000 0.7177%
2/25/26 Fiscal year

Director

8,477,131 10.1402%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+0.28%+48.72%+70.59% 28M
+0.80%+7.16%+30.89%+11.30% 222B
-0.81%+6.73%+4.06%-18.61% 147B
+2.04%+8.73%-15.14%+31.50% 139B
+1.54%+4.57%-50.04%+0.60% 73.13B
+1.79%+4.65%+19.97%+18.08% 53.05B
+1.07%+1.51%-13.73%-16.11% 50.36B
+0.54%+7.53%+31.14%+17.98% 42B
+0.73%+4.78%+48.59%+42.29% 40.43B
-0.04%+3.79%-0.10%+1.86% 32.95B
Average +0.78%+195.80%+10.44%+15.95% 79.98B
Weighted average by Cap. +0.84%+308.17%+6.65%+8.58%

Financials

2024 2025
Net sales 7K 6.07K 5.68K 5.18K 9.75K 668K 9.91K 66.59K 26.09K 334K 26.28K 25.71K 1.11M 767K 665K 622K 568K 1.07M 73.16M 1.09M 7.3M 2.86M 36.62M 2.88M 2.82M 122M
Net income -2.42M -2.09M -1.96M -1.79M -3.37M -231M -3.42M -22.99M -9.01M -115M -9.08M -8.88M -385M -3.2M -2.77M -2.59M -2.37M -4.45M -305M -4.53M -30.4M -11.91M -153M -12M -11.74M -509M
Net Debt 1.77M 1.53M 1.44M 1.31M 2.47M 169M 2.51M 16.85M 6.6M 84.55M 6.65M 6.5M 282M 2.88M 2.49M 2.33M 2.13M 4.01M 274M 4.07M 27.36M 10.72M 137M 10.8M 10.56M 458M
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
26-08-11 $0.2900 0.00% 4,102
  1. Stock Market
  2. Stocks
  3. GTHP Stock